Quality Assurance Scheme Development Group
The Quality Assurance Scheme Development Group (QASDG) will develop the European Quality Assurance Scheme for Breast Cancer Services (the European QA scheme) to set common quality and safety requirements for person-centred breast cancer services in Europe. The scheme will cover all the processes of breast cancer care (screening, diagnosis, treatment, rehabilitation & supportive care, follow-up & survivorship care and palliative care) and will be underpinned by the accreditation legal framework and evidence from guidelines.
The QASDG discusses and selects the requirements within virtual working environments and in meetings organised every three months. The initial draft documents and the final versions before piloting are subject of open calls for feedback launched online. After piloting, the so validated scheme will become operative on voluntary basis throughout Europe.
The members are also invited to contribute to the other ECIBC objectives, the Digital Mammography Training Template and the European Guidelines Platform covering all processes of care (from screening to end-of-life care).
The QASDG is supported by the external contractors EA- European Co-operation for Accreditation for the accreditation legal framework and for the coordination of national accreditation bodies, by CCIb –Iberoamerican Cochrane Centre for literature review and by IQ healthcare to develop indicators.
Members and external experts
A former nurse who is now an experienced patient advocate after treatment for breast cancer. Professional experience includes Nursing, Midwifery, Health Visiting and Palliative Care – was Nursing Director for Community Team providing access to 24hour specialist advice and support for patients and families in their homes.
Has worked with Breakthrough, Breast Cancer Campaign, Breast Cancer Care, Macmillan, CR-UK, NCRI Breast Clinical Study Group
Was the lay member of Marmot Panel on Breast Screening and Amanda Ramirez’ Working Group designing new breast bowel and cervical screening information.
Current member of SLOANE Project (audit of screen detected DCIS from the National Breast Screening Programme), Member of TMG for many breast trials LORIS ( Low Risk DCIS Surgery or Active Monitoring Trial), Lay member ASCO Breast Guideline Group, Confederation of Cancer Biobanks, Stakeholder Group at Human Tissue Authority, All Party Parliamentary Group on Cancer. Presented at many conferences including recent Breast Screening conferences in Dublin and Cambridge.
Founder member & President of Independent Cancer Patients’ Voice – a patient led group which provides education, mentoring and support for people who, having been treated for cancer, want to add the important informed patient perspective to cancer research. ICPV runs educational events at Academic Units across the UK including a unique 5 day residential “Science for Advocates” course which combines lectures with lab based “hands-on” experience.